By Sarah Stewart2013-06-18T12:17:00
Cambridge Biomedical Campus has been selected as the site of AstraZeneca/MedImmune’s new global research and development centre and corporate headquarters, in a deal tipped by Property Week.
You must be logged in to continue
Try Property Week For Free to finish this article.
Sign up now for the following benefits:
To access this article TRY FOR FREE NOW
Don’t want full access? REGISTER NOW to read this article and up to 3 more this month and subscribe to our newsletters.
Registered users and subscribers SIGN IN here to continue
Site powered by Webvision Cloud